Dastinib: new drug for mesothelioma

Although, there is currently no cure for mesothelioma. Dastinib, a new drug for treating mesothelioma has been discovered and is currently being tested in clinical trials at MD Cancer Center at the University of Texas and other centers in the United States. At Anderson Cancer Center, some patients will receive more attention for better treatment by a panel of doctors who have been assigned specific roles. This team consists of experts in the fields of chest medical oncology, radiotherapy and pathology of the lungs. The drugs Dastanib is used for mesothelioma patients who have failed other treatments or unable to take standard medications for allergic reactions or unusual side effects. Mesothelioma still has no cure, like other forms of cancer. Researchers continue to find a cure for the rare and fatal disease, whose victims find little time for life with the typical treatment for cancer such as radiotherapy, chemotherapy, etc. The introduction of Dastanib M.D. Cancer Center at the University of Texas bring the little hope for the patients. It is believed to be the best treatment to prevent progression of mesothelioma.